D.E. Shaw & Co
BPMC

D.E. Shaw & Co’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-388,986
Closed -$34.4M 3115
2025
Q1
$34.4M Buy
388,986
+27,185
+8% +$2.41M 0.03% 448
2024
Q4
$31.6M Buy
361,801
+106,111
+41% +$9.26M 0.02% 514
2024
Q3
$23.7M Sell
255,690
-46,945
-16% -$4.34M 0.02% 598
2024
Q2
$32.6M Sell
302,635
-73,542
-20% -$7.93M 0.03% 403
2024
Q1
$35.7M Buy
376,177
+26,860
+8% +$2.55M 0.03% 386
2023
Q4
$32.2M Buy
349,317
+335,279
+2,388% +$30.9M 0.03% 386
2023
Q3
$705K Buy
+14,038
New +$705K ﹤0.01% 2198
2023
Q2
Sell
-21,270
Closed -$957K 3109
2023
Q1
$957K Sell
21,270
-18,086
-46% -$814K ﹤0.01% 2230
2022
Q4
$1.72M Buy
39,356
+7,807
+25% +$342K ﹤0.01% 2114
2022
Q3
$2.08M Sell
31,549
-6,298
-17% -$415K ﹤0.01% 2090
2022
Q2
$1.91M Sell
37,847
-13,522
-26% -$683K ﹤0.01% 2289
2022
Q1
$3.28M Sell
51,369
-128,398
-71% -$8.2M ﹤0.01% 2045
2021
Q4
$19.3M Sell
179,767
-27,382
-13% -$2.93M 0.02% 724
2021
Q3
$21.3M Sell
207,149
-63,948
-24% -$6.57M 0.02% 672
2021
Q2
$23.8M Buy
271,097
+13,355
+5% +$1.17M 0.02% 657
2021
Q1
$25.1M Sell
257,742
-19,892
-7% -$1.93M 0.02% 609
2020
Q4
$31.1M Sell
277,634
-23,454
-8% -$2.63M 0.03% 525
2020
Q3
$27.9M Buy
301,088
+262,769
+686% +$24.4M 0.03% 494
2020
Q2
$2.99M Sell
38,319
-106,462
-74% -$8.3M ﹤0.01% 1418
2020
Q1
$8.47M Sell
144,781
-13,489
-9% -$789K 0.01% 823
2019
Q4
$12.7M Buy
158,270
+47,339
+43% +$3.79M 0.01% 751
2019
Q3
$8.15M Sell
110,931
-128,502
-54% -$9.44M 0.01% 926
2019
Q2
$22.6M Buy
239,433
+150,365
+169% +$14.2M 0.03% 536
2019
Q1
$7.13M Buy
+89,068
New +$7.13M 0.01% 990
2018
Q2
Sell
-27,613
Closed -$2.53M 2574
2018
Q1
$2.53M Buy
+27,613
New +$2.53M ﹤0.01% 1400
2017
Q1
Sell
-38,097
Closed -$1.07M 2423
2016
Q4
$1.07M Buy
38,097
+14,942
+65% +$419K ﹤0.01% 1723
2016
Q3
$688K Buy
+23,155
New +$688K ﹤0.01% 1880
2015
Q3
Sell
-34,191
Closed -$906K 2551
2015
Q2
$906K Buy
+34,191
New +$906K ﹤0.01% 1896